MGC Diagnostics’ COVID-19 Response Plan

Learn More
  • Home
  • News
  • Lab Infection Control - COVID-19

Lab Infection Control - COVID-19


As concern over the COVID-19 virus continues to grow and many labs are discontinuing all non-essential testing, MGC Diagnostics has received many inquiries as to the best practice for infection control when using our devices. Our products, although not critical care or emergency medical devices, are used to assess, diagnose and monitor the effect of COVID-19 on patients. The safety of our customers, their staff and patients is of utmost importance to us.  

Having clear and defined infection control policies is important for your protection. 

As such, we wanted to provide some guidance regarding infection control and cleaning options. 

MGC Diagnostics gives you three options for infection control – letting you make the choice that 
is right for your facility.

Simply change the filter and keep the same preVent® flow sensor and BreathPath™ patient circuit.
Change the flow sensor and patient circuit between patients and replace with disinfected components.
Dispose of the flow sensor and patient circuit after each patient.

Changing out the patient test supplies can be done in <1 min with no warm-up time or recalibration of the system.

To download the latest Product Bulletin on Cleaning and Disinfection Instructions of  MGC Diagnostics parts and supplies, click on the link below:

> Download Cleaning and Disinfection Instructions

MGC Diagnostics continues to monitor the COVID-19 pandemic. We are dedicated to providing cardiorespiratory diagnostic health solutions. If you have any questions or need more information, please call our Technical Support team at 1.800.333.4137 or email us at

© 2012-2020 MGC Diagnostics Corporation. All Rights Reserved. Privacy Policy | Terms of Use
MGC Diagnostics and its affiliates are equal opportunity/affirmative action employers committed to cultural diversity in the workplace and complies with Executive Orders 11246 and 13496 and hereby provides notice of its compliance with FAR 52-222-26, 29 CFR Part 471, Appendix A to Subpart A, 41 C.F.R. 60-1.4, 41 C.F.R. 60-250.5, and 41 C.F.R. 60-741.5.